Explore Stanford technologies available for licensing:

Researchers at Stanford have developed a protein, PopTag, that drives phase separation when it is part of a chimeric fusion protein.

Researchers at Stanford have developed methods for the continuous real-time monitoring of biomolecules in live subjects.

Stanford inventors have developed a wearable breath-based non-invasive sampler capable of collecting large quantities of exhaled viruses & pathogens over prolonged periods of time.

A team of Stanford researchers has invented a product that can be used to provide relief to patients with hyperhidrosis (excessive sweating), with a particular focus on palmar hyperhidrosis (excessive sweating of the hands).

Stanford researchers in the Kanan Lab have patented a low-cost, portable, and easy-to-use device designed to rapidly detect elevated ammonia levels from a drop of blood.

MECA-99 is a previously unpublished EC-specific rat monoclonal antibody (mAb), which in most settings selectively stains capillary EC in adult mice.

Mice that are homozygous for the targeted mutation have a complete cleft of the secondary palate and die within 12 hours of birth. Heterozygotes are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities.

Stanford researchers at The Lee Lab have discovered a novel epidermal tumor suppressor to treat squamous cell carcinoma (SCC) by utilizing existing drug therapies.

Stanford inventors have developed a rapid fluorogenic assay for screening of lactam resistant bacterial pathogens. ?-lactam antibiotics are considered to be the most successful class of antibiotics for treating bacterial infections.

Researchers at Stanford have described, for the first time, the formation of a human neural circuit loop from stem cells in human assembloids.

Stanford researchers have designed hydrogels that can be delivered to surgical sites in a patient's body for controlled and sustained release of bacteriophages to treat or prevent bacterial infections.

Researchers at Stanford have developed a magnetophoretic separation device (MSD) for isolating basophils and other rare cell types from a blood sample. The device applies exponentially increasing magnetic field strength to flowing magnetically tagged cells.

Researchers at Stanford have developed non-opiate methods for treating chronic pain and for retrograde transduction of neurons.

Stanford researchers have developed a new transcatheter, minimally invasive neochordal device for repair of mitral regurgitation, which does not require open heart surgery nor cardiopulmonary bypass.

Inspired by the "last inch" problem in robotic manipulation, the Kennedy group at Stanford has developed a tactile sensor and calibration method for machine-learning-based robotic manipulation.